期刊文献+

晚期子宫内膜癌预后相关因素分析 被引量:2

Analysis of prognostic factors of advanced endometrial carcinoma
下载PDF
导出
摘要 目的 探讨晚期子宫内膜癌预后相关因素。方法 回顾性分析我院1986年1月~1999年9月间收治的41例晚期子宫内膜癌患者临床病理资料和随访结果。结果(1)41例患者,Ⅲ期30例,其中Ⅲa期15例(36.6%),Ⅲb期3例(7.3%),ⅢC期12例(29.3%),Ⅳ期11例(26.8%)(均为Ⅳb期);子宫内膜样腺癌30例(73.2%),腺鳞癌5例(12.2%),浆乳癌5例(12.2%),透明细胞癌1例(2.4%);单纯手术2例,单纯放疗3例,单纯孕激素治疗1例,综合治疗35例;死亡17例,5年生存率35.4%。(2)Ⅲ期患者中,Ⅲa期复发3例,死亡2例,5年生存率65.6%;Ⅲb期盆腹腔复发1例(死亡),Ⅲc期复发转移8例,均死亡,5年生存率14.5%。(3)Ⅳ期患者中,盆腹腔复发3例,肺转移5例,死亡6例,3年生存率 27.7%。(4)子宫外多处癌灶22例,其中复发转移16例,死亡14例,占全部死亡的82.4%。结论 子宫内膜癌Ⅲc期预后明显差于Ⅲa期,子宫浆膜受侵、子宫外多处癌灶、宫旁组织受侵犯、宫旁淋巴管或血管有癌栓及淋巴结癌转移仍是影响Ⅲ期子宫内膜癌预后的重要因素,Ⅳ期患者易盆腹腔复发和肺转移,预后更差,晚期子宫内膜癌应进行综合治疗。 Objective To study the prognostic factors of advanced endometrial carcinoma. Methods Analysis of the clinical of pathological features of 41 cases of advanced endometrial carcinoma. Results (1) There were 41 cases of endometrial carcinoma in which 15 IIIa (36.6%), 3 IIIb (7.3%). 12 Die (29.3%) and 11 cases of stage IV b (26.8%). Histo-logically 30 cases (73.2% ) were endornetrioid, 5 adenosquamous (12.2% ), 5 papillary serous adenocarcinoma (12.2% ), and 1 clear cell carcinoma (2.4%). 2 cases were treated by surgery alone, 3 cases radiotherapy only, 1 case progesterone only, and combined treatment for 35 cases. 17 cases died, with a five year survival rate as 35.4% . (2) In the stage II cases, 3 IIIa recurred, 2 died, with a 5 year survival rate as 65.6% ; 1 III b recurred and died; 8 IIIc recurred and all died with the 5 year survival rate as 14.5% . (3) In stage IV cases, 3 had pelvic recurrence, 5 lung metastasis, and 6 died with a 3 year survival rate as 27.7%. (4) There were 22 cases with multiple extrauterine metastasis, in which 16 recurred, 14 died which was 82.4% of all the dead cases. Conclusion The prognosis of stage III c endometrial carcinoma was worse than that of stage ID a. The involvement of uterine serosa, lymph node metastasis, multi - lesion out of uterine, and lymphovascular invasion (LVI) were the important prognostic factors of stage III endometrial carcinoma. The recurrence of pelvic and peritoneal cavity and peritoneal cavity and long distance metastasis were found much more in stage IV b, which made a poor prognosis. Combined treatment should be given in these late cases.
出处 《中国妇产科临床杂志》 2000年第1期12-14,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 子宫内膜癌 治疗 预后 晚期 Endometrial carcinoma Advanced stage Treatment Prognosis
  • 相关文献

参考文献7

  • 1Burke TV,Fowler WC,Worrow WC.Clinical aspects or risk in women with endometrial carcinoma. Journal of Cellular Biochemistry . 1995
  • 2Calais G,Descamps P,Vitu L,et al.Is lymphadenectomy useful in the treatment of endometrial carcinoma. Gynecologic Oncology . 1990
  • 3Morrow CP,Bundy BN,Kurman BJ,et al.Relationship between surgical-pathological risk factors and outcome in clinical stage Ⅰ and Ⅱ carcinoma of the endometrium: a gnecologic oncology group study. Gynecologic Oncology . 1991
  • 4Lurain JR,Rice BL,Rademarker AW,et al.Prognostic factors associated with recurrence in clinical stage Ⅰ adenocarcinoma of the endometrium. Obstetrics and Gynecology . 1991
  • 5Greven KM,Lanciano RM,Com B,et al.Pathologic stage Ⅲ endometrial carcinoma. Cancer . 1993
  • 6Morris PC,Anderson JR,Anderson B. et al.Steriod hormone receptor content and lymph node status in endometrial cancer. Gynecologic Oncology . 1995
  • 7Genes P.Stage Ⅲ carcinoma of the endomentrium: a review of 41 cases. Gynecologic Oncology . 1987

同被引文献16

  • 1李斌,吴令英,李淑敏,章文华,张蓉,马绍康.子宫内膜癌的预后影响因素分析[J].癌症,2004,23(9):1085-1088. 被引量:31
  • 2邓文慧,吴文英,何淑蓉,张毅.子宫内膜癌的临床病理分析[J].中国医刊,2004,39(9):36-39. 被引量:3
  • 3王志启,王建六,郭健,魏丽惠.内分泌辅助治疗子宫内膜癌的临床意义[J].中华医学杂志,2005,85(34):2414-2419. 被引量:21
  • 4吴宜勇.老年女性骨质疏松与激素治疗[J].中华老年医学杂志,2006,25(6):414-415. 被引量:8
  • 5Grundker C,Gunthert AR,Emons G.Hormonal heterogeneity of endometrial cancer.Adv Exp Med Biol,2008,630:166-188.
  • 6Uharcek P.Prognostic factors in endometrial carcinoma.J Obstet Gynaecol Res,2008,34:776-783.
  • 7Lachance A,Everett B,Greer AB,et al.The effect of age on clinical/pathologic features,surgical morbidity,and outcome in patients with endometrial caner.Gyneco Oncol,2006,101:470-475.
  • 8Mueller MD,Vigne JL,Pritts EA,et al.Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells.Fertil Steril,2003,79:386-392.
  • 9Di NLA,Jobling T,Salamonsen LA.Progeatin suppresses matrix metalloproteinase production in endometrial cancer.Gyncol Oncol,2003,89:325-333.
  • 10Femial RA,Goyette RE.The science of megestrol acetate delivery po-tential to improve outcomes in cachexia.Bio Drugs,2005,19:179-187.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部